CAVIN3
Caveolae-associated protein 3
Also known as: cavin-3, CAVN3_HUMAN, HSRBC, MGC20400, PRKCDBP, SRBC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969G5
- Gene
- CAVIN3
- Ensembl
- ENSG00000170955
- Chromosome
- 11
- Canonical length
- 261 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene was identified as a binding protein of the protein kinase C, delta (PRKCD). The expression of this gene in cultured cell lines is strongly induced by serum starvation. The expression of this protein was found to be down-regulated in various cancer cell lines, suggesting the possible tumor suppressor function of this protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
261 residues, UniProt reviewed canonical sequence.
>Q969G5|CAVIN3
1 MRESALERGP VPEAPAGGPV HAVTVVTLLE KLASMLETLR ERQGGLARRQ GGLAGSVRRI
61 QSGLGALSRS HDTTSNTLAQ LLAKAERVSS HANAAQERAV RRAAQVQRLE ANHGLLVARG
121 KLHVLLFKEE GEVPASAFQK APEPLGPADQ SELGPEQLEA EVGESSDEEP VESRAQRLRR
181 TGLQKVQSLR RALSGRKGPA APPPTPVKPP RLGPGRSAEA QPEAQPALEP TLEPEPPQDT
241 EEDPGRPGAA EEALLQMESV ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CAVIN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 292 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 292 nTPM
- endometrium: 121 nTPM
- cervix: 91 nTPM
- colon: 82 nTPM
- adipose tissue: 80 nTPM
- urinary bladder: 78 nTPM
Single-cell type
- late primary spermatocytes: 813 nCPM
- vascular smooth muscle cells: 431 nCPM
- decidual stromal cells: 296 nCPM
- late spermatids: 292 nCPM
- hepatic stellate cells: 291 nCPM
- smooth muscle cells: 243 nCPM
Immune cell
- myeloid DC: 43 nTPM
- classical monocyte: 16 nTPM
- T-reg: 6.1 nTPM
- total PBMC: 5.9 nTPM
- intermediate monocyte: 1.1 nTPM
- memory CD4 T-cell: 0.8 nTPM
Brain region
- choroid plexus: 18 nTPM
- thalamus: 8 nTPM
- pons: 7.1 nTPM
- basal ganglia: 6.8 nTPM
- medulla oblongata: 6.5 nTPM
- amygdala: 6.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.81
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- circadian regulation of gene expression
- cortical actin cytoskeleton organization
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of ERK1 and ERK2 cascade
- negative regulation of fermentation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CAVIN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CAVIN3 as an antibody target. Whether an autoantibody or antibody against CAVIN3 could matter depends on whether native CAVIN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CAVIN3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CAVIN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...